Synthesis and biological evaluation of 4′-(6,7-disubstituted-2,4-dihydro-indeno[1,2-c]pyrazol-3-yl)-biphenyl-4-ol as potent Chk1 inhibitors
- 1 August 2007
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 17 (15) , 4308-4315
- https://doi.org/10.1016/j.bmcl.2007.05.027
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- 3-(Indol-2-yl)indazoles as Chek1 kinase inhibitors: Optimization of potency and selectivity via substitution at C6Bioorganic & Medicinal Chemistry Letters, 2006
- Selective Chk1 inhibitors differentially sensitize p53‐deficient cancer cells to cancer therapeuticsInternational Journal of Cancer, 2006
- 4-(Aminoalkylamino)-3-benzimidazole-quinolinones as potent CHK-1 inhibitorsBioorganic & Medicinal Chemistry Letters, 2006
- Synthesis and biological evaluation of 1-(2,4,5-trisubstituted phenyl)-3-(5-cyanopyrazin-2-yl)ureas as potent Chk1 kinase inhibitorsBioorganic & Medicinal Chemistry Letters, 2006
- Synthesis and biological evaluation of 3-ethylidene-1,3-dihydro-indol-2-ones as novel checkpoint 1 inhibitorsBioorganic & Medicinal Chemistry Letters, 2006
- Cell-cycle checkpoints and cancerNature, 2004
- Molecular Mechanisms of Mammalian DNA Repair and the DNA Damage CheckpointsAnnual Review of Biochemistry, 2004
- Chk1 in the DNA damage response: conserved roles from yeasts to mammalsDNA Repair, 2004
- DNA and its associated processes as targets for cancer therapyNature Reviews Cancer, 2002
- BRCA1 regulates the G2/M checkpoint by activating Chk1 kinase upon DNA damageNature Genetics, 2002